Stephen J. Polyak
机构: University of Washington
每年引用次数
引用次数
引用: 12,012
H-指数: 55
I10-指数 : 99
出版物: 186
Characterization of Pichinde Arenavirus Infection and Replication in Cell Cultures
John Stephen Polyak
1993
Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients.
D R Gretch , S J Polyak , J J Wilson , R L Carithers
Journal of Virology 70 ( 11) 7622 -7631
144
1996
Elimination of hepatitis C virus RNA in infected human hepatocytes by adenovirus-mediated expression of ribozymes.
A Lieber , C Y He , S J Polyak , D R Gretch
Journal of Virology 70 ( 12) 8782 -8791
93
1996
Characterization of Pichinde virus infection of cells of the monocytic lineage.
S J Polyak , W E Rawls , D G Harnish
Journal of Virology 65 ( 7) 3575 -3582
16
1991
5' termini of Pichinde arenavirus S RNAs and mRNAs contain nontemplated nucleotides.
S J Polyak , S Zheng , D G Harnish
Journal of Virology 69 ( 5) 3211 -3215
37
1995
Prospective multicenter clinical evaluation of AMPLICOR and COBAS AMPLICOR hepatitis C virus tests.
F. S. Nolte , M. W. Fried , M. L. Shiffman , A. Ferreira-Gonzalez
Journal of Clinical Microbiology 39 ( 11) 4005 -4012
44
2001
A versatile ribosomal protein promoter-based reporter system for selective assessment of RNA stability and post-transcriptional control.
E. Hitti , S. Al-Yahya , M. Al-Saif , P. Mohideen
RNA 16 ( 6) 1245 -1255
22
2010
Direct, interferon-independent activation of the CXCL10 promoter by NF-κB and interferon regulatory factor 3 during hepatitis C virus infection
J. Brownell , J. Bruckner , J. Wagoner , E. Thomas
Journal of Virology 88 ( 3) 1582 -1590
74
2014
Detection of Hepatitis C Virus RNA in Normal Cervical Smears
C. Wang , S. J. Polyak , L. Corey
Clinical Infectious Diseases 37 ( 2) 314 -314
1
2003
Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.
C. E. Hulseberg , L. Fénéant , K. M. Szymańska-de Wijs , N. P. Kessler
Journal of Virology 93 ( 8)
57
2019
Evidence for sequence selection within the non‐structural 5A gene of hepatitis C virus type 1b during unsuccessful treatment with interferon‐α
M. Gerotto , F. Dal Pero , D. G. Sullivan , L. Chemello
Journal of Viral Hepatitis 6 ( 5) 367 -372
26
1999
Prospective Characterization of Full-Length Hepatitis C Virus NS5A Quasispecies during Induction and Combination Antiviral Therapy
J.-B. Nousbaum , S. J. Polyak , S. C. Ray , D. G. Sullivan
Journal of Virology 74 ( 19) 9028 -9038
125
2000
Characterization of simple and complex hepatitis C virus quasispecies by heteroduplex gel shift analysis: correlation with nucleotide sequencing.
J. J. Wilson , S. J. Polyak , T. D. Day , D. R. Gretch
Journal of General Virology 76 ( 7) 1763 -1771
65
1995
Identification of hepatoprotective flavonolignans from silymarin
S. J. Polyak , C. Morishima , V. Lohmann , S. Pal
Proceedings of the National Academy of Sciences of the United States of America 107 ( 13) 5995 -5999
207
2010
Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants.
D.A. Fidock , P.J. Weathers , S.J. Polyak , M.J. Towler
Journal of Ethnopharmacology 274 114016 -114016
3
2021
763 NARINGENIN INHIBITS THE ASSEMBLY AND LONG-TERM PRODUCTION OF INFECTIOUS HEPATITIS C VIRUS (HCV) PARTICLES THROUGH A PPAR-MEDIATED MECHANISM
Y. Nahmias , S.J. Polyak , R.T. Chung
Journal of Hepatology 52 ( supp-S1) 0
2010
Innate intracellular defence against HIV and its modulation by HCV gene product
P Polyak
Postgraduate Course, Vienna 30 -33
10
2006
Halloysite support for an enzyme and its use for the controlled enzymatic degradation of PCL
N Hegyesi , K Hodosi , P Polyak , D Balogh-Weiser
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 124 3 -3
2018
Influence of ply thickness on failure initiation, propagation and mechanical properties in CFRP laminates
B Kötter , P Polyak , Johann Körbelin , B Fiedler
Proceedings of ICFC 7
3
2018
In the article “Cancer and Liver Cancer Prevention: Is It a Fact or Just a Potential?”(HEPATOLOGY 2008; 48: 7-9
STEPHEN J POLYAK , CHIHIRO MORISHIMA